Sziklavari Zsolt, Grosser Christian, Neu Reiner, Schemm Rudolf, Kortner Ariane, Szöke Tamas, Hofmann Hans-Stefan
Department of Thoracic Surgery, Hospital Barmherzige Brüder Regensburg, Prüfeningerstrasse 86, 93049 Regensburg, Germany.
J Cardiothorac Surg. 2011 Oct 6;6:130. doi: 10.1186/1749-8090-6-130.
For patients with postoperative pleural empyema, open window thoracostomy (OWT) is often necessary to prevent sepsis. Vacuum-assisted closure (VAC) is a well-known therapeutic option in wound treatment. The efficacy and safety of intrathoracal VAC therapy, especially in patients with pleural empyema with bronchial stump insufficiency or remain lung, has not yet been investigated.
Between October 2009 and July 2010, eight consecutive patients (mean age of 66.1 years) with multimorbidity received an OWT with VAC for the treatment of postoperative or recurrent pleural empyema. Two of them had a bronchial stump insufficiency (BPF).
VAC therapy ensured local control of the empyema and control of sepsis. The continuous suction up to 125 mm Hg cleaned the wound and thoracic cavity and supported the rapid healing. Additionally, installation of a stable vacuum was possible in the two patients with BPF. The smaller bronchus stump fistula closed spontaneously due to the VAC therapy, but the larger remained open. The direct contact of the VAC sponge did not create any air leak or bleeding from the lung or the mediastinal structures. The VAC therapy allowed a better re-expansion of remaining lung. One patient died in the late postoperative period (day 47 p.o.) of multiorgan failure. In three cases, VAC therapy was continued in an outpatient service, and in four patients, the OWT was treated with conventional wound care. After a mean time of three months, the chest wall was closed in five of seven cases. However, two patients rejected the closure of the OWT. After a follow-up at 7.7 months, neither recurrent pleural empyema nor BPF was observed.
VAC therapy was effective and safe in the treatment of complicated pleural empyema. The presence of smaller bronchial stump fistula and of residual lung tissue are not a contraindication for VAC therapy.
对于术后脓胸患者,胸廓造口术开窗引流(OWT)通常是预防脓毒症所必需的。负压封闭引流(VAC)是伤口治疗中一种广为人知的治疗选择。胸腔内VAC治疗的有效性和安全性,尤其是在伴有支气管残端不全或余肺的脓胸患者中,尚未得到研究。
2009年10月至2010年7月期间,8例合并多种疾病的连续患者(平均年龄66.1岁)接受了带VAC的OWT治疗术后或复发性脓胸。其中2例有支气管残端不全(BPF)。
VAC治疗确保了脓胸的局部控制和脓毒症的控制。持续高达125 mmHg的负压吸引清洁了伤口和胸腔,并促进了快速愈合。此外,在2例BPF患者中可以安装稳定的负压。较小的支气管残端瘘由于VAC治疗而自行闭合,但较大的仍未闭合。VAC海绵的直接接触未造成任何漏气或肺或纵隔结构出血。VAC治疗使余肺更好地复张。1例患者在术后晚期(术后第47天)死于多器官功能衰竭。3例患者在门诊继续接受VAC治疗,4例患者的OWT采用传统伤口护理。平均3个月后,7例患者中有5例胸壁闭合。然而,2例患者拒绝闭合OWT。随访7.7个月后,未观察到复发性脓胸或BPF。
VAC治疗复杂脓胸有效且安全。较小的支气管残端瘘和残余肺组织的存在并非VAC治疗的禁忌证。